Acadia Pharmaceuticals Inc (ACAD)
Investing Cash Flow
$57.75M
Quarterly · Period ending: · USD
ACAD Investing Cash Flow
Latest reported$57.75Mperiod ending
Latest reported$57.75Mperiod ending
ACAD Quarterly Cash from Investing ($2.75M → $57.75M)
Quarterly investing cash flow
High-resolution chart · PNG
ACAD investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 57,752,000 | |
| 66,281,000 | |
| -55,869,000 | |
| -79,352,000 | |
| -43,294,000 | |
| -124,049,000 | |
| 122,150,000 | |
| -82,457,000 | |
| -56,192,000 | |
| -14,039,000 | |
| -347,000 | |
| 34,110,000 | |
| -194,283,000 | |
| 192,518,000 | |
| -17,748,000 | |
| 15,441,000 | |
| -55,797,000 | |
| 131,345,000 | |
| 71,549,000 | |
| -156,321,000 | |
| -17,207,000 | |
| 30,877,000 | |
| -116,958,000 | |
| 152,994,000 | |
| 126,865,000 | |
| 29,608,000 | |
| -209,144,000 | |
| 9,923,000 | |
| 10,627,000 | |
| 22,758,000 | |
| -188,949,000 | |
| 31,784,000 | |
| -3,942,000 | |
| 89,618,000 | |
| -18,093,000 | |
| 19,332,000 | |
| 38,299,000 | |
| 52,935,000 | |
| 69,140,000 | |
| -154,908,000 | |
| -7,460,000 | |
| -168,696,000 | |
| 56,725,000 | |
| 8,308,000 | |
| 44,064,000 | |
| 38,473,000 | |
| 40,476,000 | |
| 38,873,000 | |
| -67,510,000 | |
| -99,112,000 | |
| 9,541,000 | |
| -3,943,000 | |
| -98,616,000 | |
| -33,086,000 | |
| -35,054,000 | |
| -2,744,000 | |
| 8,393,000 | |
| 3,877,000 | |
| 3,815,000 | |
| 4,478,000 | |
| 6,422,000 | |
| -8,735,000 | |
| -7,761,000 | |
| 2,943,000 | |
| -2,761,000 | |
| 6,519,000 | |
| 8,528,000 | |
| 10,531,000 | |
| -20,805,000 | |
| 11,190,000 | |
| 11,534,000 | |
| 18,169,000 | |
| 15,376,000 | |
| 24,635,000 | |
| 7,174,000 | |
| -3,018,000 | |
| -66,029,000 | |
| 19,971,000 | |
| 967,000 | |
| -528,000 | |
| -23,979,000 | |
| 604,000 | |
| 5,949,900 | |
| 13,432,300 | |
| -23,125,800 | |
| -2,907,800 | |
| 9,608,000 | |
| 3,089,700 | |
| -22,826,700 | |
| 2,750,300 |